People and planet at heart

Our Commitment to Sustainability - Building a resilient future with people and planet at heart.

ESG Analysis 2024

We believe that sustainable business practices are not merely a responsibility but essential for building a resilient future for our stakeholders, communities, and the planet. Our environmental, social, and governance (ESG) initiatives are integrated into every facet of our operations, fostering innovation and generating a sustainable, positive impact.

The annual analysis lets our partners and customers better understand how we perceive sustainability, actions, and prioritised targets. It also serves as a crucial tool for directing our sustainability efforts and ensuring that we stay on track, delivering in a way that considers financial, environmental, and social developments.

We are committed to transparent communication about our sustainability journey. Our ESG analysis provides detailed insights into our progress, challenges, and future commitments.

 

2024 ESG Analysis

2023 ESG Analysis

Code of Conduct

Environmental policy

 


 

Our estimated climate footprint for the financial year 2024 is 34,8 tons of CO2e, equating to 1,6 tons of CO2e per co-worker. The transport of radiopharmaceuticals accounts for 28 tons of the total CO2e emissions. 

Impact objectives 2025

SAM_esg_icons-09.pngLower the fossil fuel dependency.

  • SDG 12 Responsible consumtion & production
  • SDG 13 Climate action
     

SAM_esg_icons-09.pngCo-worker mental health.

  • SDG 3 Good health & wellbeing 
  • SDG 8 Decent work conditions & economic growth 
  • SDG 10 Reduced inequalities
     

SAM_esg_icons-09.pngFind a way to measure climate actions.

  • SDG 13 Climate action

Impact goal 2026

By the end of 2026, reach the sustainable level of CO2e per co-worker. (1 ton of CO2e per co-worker.)